Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CIPROFLOXACIN Cause Product formulation issue? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product formulation issue have been filed in association with CIPROFLOXACIN (Ciprofloxacin). This represents 0.0% of all adverse event reports for CIPROFLOXACIN.

7
Reports of Product formulation issue with CIPROFLOXACIN
0.0%
of all CIPROFLOXACIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product formulation issue From CIPROFLOXACIN?

Of the 7 reports, 1 (14.3%) required hospitalization.

Is Product formulation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CIPROFLOXACIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CIPROFLOXACIN Cause?

Drug hypersensitivity (5,266) Arthralgia (3,749) Pain (3,201) Fatigue (3,056) Drug ineffective (2,918) Nausea (2,689) Neuropathy peripheral (2,607) Diarrhoea (2,599) Pain in extremity (2,522) Dyspnoea (2,340)

What Other Drugs Cause Product formulation issue?

MINOXIDIL (1,369) LEVOTHYROXINE (740) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174) OMEPRAZOLE (99) METHYLPHENIDATE (78) OXYCODONE (73) ACETAMINOPHEN\HYDROCODONE (62) ACETAMINOPHEN\OXYCODONE (61) ACETAMINOPHEN (59) BUPROPION (59)

Which CIPROFLOXACIN Alternatives Have Lower Product formulation issue Risk?

CIPROFLOXACIN vs CIPROFLOXACIN\DEXAMETHASONE CIPROFLOXACIN vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE CIPROFLOXACIN vs CISAPRIDE CIPROFLOXACIN vs CISATRACURIUM CIPROFLOXACIN vs CISPLATIN

Related Pages

CIPROFLOXACIN Full Profile All Product formulation issue Reports All Drugs Causing Product formulation issue CIPROFLOXACIN Demographics